Immune Thrombocytopenia (ITP) research hub

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

This study is testing a new medicine called pirtobrutinib for people with Immune Thrombocytopenia (ITP). It aims to see how safe it is, what side effects it might cause, and if it helps improve blood platelet counts.

A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents with Persistent or Chronic Immune Thrombocytopenia (ITP).